Table 1.
Flow cytometry analysis of hMSG-EpiPCs.
| Average | s.d. | |
|---|---|---|
| Epithelial lineage-related markers | ||
| CD29 | 99.23% | 0.76% |
| CD49f | 93.61% | 6.07% |
| CK-KIT | 95.03% | 4.90% |
| Salivary epithelial cell markers | ||
| CD44 | 83.07% | 6.44% |
| CD166 | 99.83% | 0.12% |
| Mesenchymal stem cell markers | ||
| CD90 | 2.08% | 1.36% |
| CD105 | 2.34% | 0.37% |
| CD106 | 1.87% | 0.86% |
| STRO-1 | 1.64% | 0.84% |
| Hematopoietic lineage-related markers | ||
| CD117 | 0.44% | 0.45% |
| Embryonic stem cell markers | ||
| SOX2 | 67.03% | 4.67% |
| SSEA-1 | 5.13% | 1.73% |
| NANOG | 1.11% | 0.86% |
| OCT4 | 1.99% | 1.28% |
| Other markers | ||
| ALB | 0.58% | 0.22% |
Averaged percentage of flow cytometry analysis of hMSG-EpiPCs at passage 5 for the cell markers are shown in the table. Standard deviation is shown as s.d.